Aadi Bioscience Inc (AADI)
1.675
-0.10
(-5.90%)
USD |
NASDAQ |
Apr 25, 12:16
Aadi Bioscience Cash from Investing (TTM): 83.21M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 83.21M |
September 30, 2023 | -4.822M |
June 30, 2023 | -65.73M |
March 31, 2023 | -116.53M |
December 31, 2022 | -132.89M |
Date | Value |
---|---|
September 30, 2022 | -48.55M |
June 30, 2022 | 25.05M |
March 31, 2022 | 25.13M |
December 31, 2021 | 25.15M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-132.89M
Minimum
Dec 2022
83.21M
Maximum
Dec 2023
-23.33M
Average
-4.822M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
Aquestive Therapeutics Inc | -0.995M |
89bio Inc | -123.02M |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |